Dosing Experiments
From QMRAwiki
This is a master list of dosing experiments. Many of these have been used to fit dose response models, but others have not. You can sort by column to find what you need. You can also hit control-f to find what you need. The Expt Id link will take you directly to the data set if available. The 'dose response fit' column has 4 values: fitted (it's been used to fit a dose response model), pooled (it's contributed to a dose response model), not fittable (definition needed), or not yet in wiki (the data exists, but has not yet been added to the wiki). Clicking on fitted or pooled will take you to the Dose Response model page for the agent. The Pathogen link will take you the Agent Overview page, if one exists.
Expt ID | Agent | Pathogen | Pathogen Type | Host | Host Type | Host Characteristics | Route | Response | Dose Units | Reference | Dose ResponseFit |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Bacterium | Yersinia pestis | CO92 | mouse | C57BL/6 | intranasal | death | CFU | [1] | fitted | |
2 | Bacterium | Yersinia pestis | KIM D27 | mouse | C57BL/6 | intranasal | death | CFU | [2] | fitted | |
3 | Bacterium | Yersinia pestis | CO92 | mouse | BALB/c | intraperitoneal | death | CFU | [3] | fitted | |
4 | Bacterium | Yersinia pestis | 195/P | langur | Presbytis entellus | subcutaneous | death | CFU | [4] | not yet in wiki | |
5 | Bacterium | Yersinia pestis | 195/P | langur | Presbytis cristata | subcutaneous | death | CFU | [5] | not fittable | |
6 | Bacterium | Yersinia pestis | 195/P | grivet | subcutaneous | death | CFU | [6] | not yet in wiki | ||
7 | Bacterium | Yersinia pestis | monkey | rhesus | inhalation | death | Average no. organisms inhaled | [7] | not yet in wiki | ||
8 | Bacterium | Yersinia pestis | Alexander | mouse | albino | intracutaneous | death | CFU | [8] | not yet in wiki | |
9 | Bacterium | Variola major | mouse | aged 0-24 hours | intraperitoneal | death | pock forming unit | [9] | fitted | ||
10 | Bacterium | Variola major | mouse | aged 24-48 hours | intraperitoneal | death | pock forming unit | [10] | fitted | ||
11 | Bacterium | Variola major | mouse | aged 48-120 hours | intraperitoneal | death | pock forming unit | [11] | fitted | ||
12 | Bacterium | Variola major | mouse | aged 120-168 hours | intraperitoneal | death | pock forming unit | [12] | fitted | ||
13 | Virus | Lassa virus | guinea pig | inbred, USAMRIID strain 13 | 450-600g | subcutaneous | PFU | [13] | fitted | ||
14 | Virus | Lassa virus | guinea pig | outbred, Hartley strain | 450-500g | subcutaneous | PFU | [14] | not yet in wiki | ||
15 | Virus | Lassa virus | guinea pig | outbred, Hartley strain | 180-300g | inhalation | death | PFU | [15] | fitted | |
16 | Virus | Lassa virus | guinea pig | outbred, Hartley strain | 180-300g | inhalation | morbidity | PFU | [16] | not fittable | |
17 | Bacterium | Burkholderia pseudomallei | KHW | mouse | BALB/c | female, age 5-6w | intranasal | CFU | [17] | fitted | |
18 | Bacterium | Burkholderia pseudomallei | KHW | mouse | C57BL/6 | female, age 5-6w | intranasal | CFU | [18] | fitted | |
19 | Bacterium | Burkholderia mallei | SR1 | hamster | Syrian | intraperitoneal | death | CFU | [19] | not fittable | |
20 | Bacterium | Burkholderia mallei | tssE-/tssE+ | hamster | Syrian | intraperitoneal | death | CFU | [20] | not yet in wiki | |
21 | Bacterium | Burkholderia pseudomallei | W294 | guinea pig | intraperitoneal | death | CFU | [21] | fitted | ||
22 | Bacterium | Burkholderia mallei | C7 | guinea pig | intraperitoneal | death | CFU | [22] | not fittable | ||
23 | Bacterium | Burkholderia pseudomallei | 316c | rat | outbred, Sprague-Dawley | 30g, diabetic | intraperitoneal | death | CFU | [23] | not yet in wiki |
24 | Bacterium | Coxiella burnetii | Nine mile phase I | guinea pig | outbred, Hartley strain | female, age 6-8w | inhalation | fever | no. organisms | [24] | not fittable |
25 | Bacterium | Coxiella burnetii | Nine mile phase I | mouse | SCID | intraperitoneal | death | TCID50 doses | [25] | not yet in wiki | |
26 | Bacterium | Coxiella burnetii | Nine mile phase I | mouse | C57BL/6J | intraperitoneal | death | no. organisms | [26] | fitted | |
27 | Bacterium | Coxiella burnetii | Nine mile phase I | mouse | A/J | intraperitoneal | death | no. organisms | [27] | not fittable | |
28 | Bacterium | Coxiella burnetii | phase I Ohio | mouse | C57BL/10ScN | male | intraperitoneal | death | no. organisms | [28] | fitted |
29 | Bacterium | Coxiella burnetii | phase I AD | human | male, young adult | inhalation | clinical signs | guinea pig infectious dose | [29] | not yet in wiki | |
30 | Virus | adenovirus | APC | human | inhalation | infection | [30] | not fittable | |||
31 | Virus | adenovirus | type 4 | inhalation | [31] | fitted | |||||
32 | Virus | astrovirus | human | oral | [32] | not fittable | |||||
33 | Bacterium | Vibrio cholerae | classical | [33] | not fittable | ||||||
34 | Bacterium | Vibrio cholerae | El Tor | [34] | not fittable | ||||||
35 | Bacterium | Vibrio cholerae | Inaba 569B | human | adult male prisoners | oral (no NaHCO3) | diarrhea or culture positive | CFU | [35] | fitted | |
36 | Protozoan | Cryptosporidium parvum | morbidity | [36] | not fittable | ||||||
37 | Bacterium | cyanobacteria | mouse | [37] | not fittable | ||||||
38 | Bacterium | Escherichia coli | ETEC B7A | human | male prisoner | oral (in milk) | mild to severe diarrhea | cells | [38] | pooled | |
39 | Bacterium | Escherichia coli | EIEC 4608 | human | male prisoner | oral (in milk) | mild to severe diarrhea | cells | [39] | fitted | |
40 | Bacterium | Escherichia coli | EIEC 1624 | human | male prisoner | oral (in milk) | mild to severe diarrhea | cells | [40] | fitted | |
41 | Bacterium | Escherichia coli | EIEC 1624 | human | male prisoner | oral (w. 2g NaHCO3) | severe diarrhea | cells | [41] | not fittable | |
42 | Bacterium | Escherichia coli | ETEC O55 (in paper as “type 55, B5”) | human | male prisoner | oral | slight to severe illness | organisms | [42] | fitted | |
43 | Bacterium | Escherichia coli | ETEC O111 (in paper as “E. coli 111, B4”) | human | male prisoner | oral | slight to severe illness | organisms | [43] | fitted | |
44 | Virus | echovirus | 12 | human | infection | [44] | not yet in wiki | ||||
45 | Protozoan | Endamoeba coli | From an infected human | human | male prisoner | oral | infection | no. cysts | [45] | fitted | |
46 | Protozoan | Giardia sp. | From an infected human | human | male prisoner | oral | infection | no. cysts | [46] | fitted | |
47 | Protozoan | Giardia sp. | From infected humans | beaver | trapped near Minneapolis | oral | infection | no. cysts | [47] | fitted | |
48 | Protozoan | Giardia sp. | From infected humans | muskrat | trapped near Minneapolis | stomach tube | infection | no. cysts | [48] | fitted | |
49 | Protozoan | Giardia sp. | unknown | human | visitors & residents of Aspen Highlands, CO | oral | diarrhea | glasses of water | [49] | not fittable | |
50 | Bacterium | Giardia muris | mouse | C3H/H3N | specific-pathogen-free, 6-8 week old male mice | oral | infection | cysts | [50] | not yet in wiki | |
51 | Virus | hepatitis A | From an infected human | human | child | “mentally defective” 5-10 year olds | oral | jaundice | equivalents to grams of stool | [51] | not yet in wiki |
52 | Virus | hepatitis A | From an infected human | human | child | “mentally defective” 5-10 year olds | oral | jaundice | equivalents to grams of stool | [52] | not yet in wiki |
53 | Virus | parainfluenza virus | type 2 | human | adult | infection | [53] | not yet in wiki | |||
54 | Virus | parainfluenza virus | type 2 | human | adult | morbidity | [54] | not yet in wiki | |||
55 | Virus | parainfluenza virus | type 3 | hamster | [55] | not yet in wiki | |||||
56 | Virus | poliovirus | type 1, attenuated | [56] | not yet in wiki | ||||||
57 | Virus | poliovirus | type 1, attenuated | human | infant | infection | [57] | not fittable | |||
58 | Virus | poliovirus | type 2, attenuated | [58] | not yet in wiki | ||||||
59 | Virus | poliovirus | type 2 | [59] | not fittable | ||||||
60 | Virus | poliovirus | type 3, attenuated | human | [60] | not fittable | |||||
61 | Virus | poliovirus | type 2 | [61] | not yet in wiki | ||||||
62 | Virus | enterovirus | porcine, PE3-ECPO-6 | pig | [62] | fitted | |||||
63 | Virus | enterovirus | porcine, PE7-05i | pig | [63] | fitted | |||||
64 | Virus | rhinovirus | type 14 | human | [64] | fitted | |||||
65 | Virus | rhinovirus | type 39 | human | [65] | fitted | |||||
66 | Virus | rotavirus | OSU | pig | specific-pathogen-free, colostrum-deprived, caesarean-derived newborn piglets | oral | infection | PFU | [66] | not fittable | |
67 | Virus | rotavirus | MET strain, serotype 3, subgroup II | mouse | Swiss SW55 | newborn | oral | infection | TCID50 doses | [67] | not yet in wiki |
68 | Virus | rotavirus | OSU (ATCC VR892) | pig | 4-5 day old colostrum-deprived piglets | intragastric | infection | particles | [68] | fitted | |
69 | Virus | rotavirus | CJN strain (unpassaged) | human | healthy 18-45 year old men | oral | infection | FFU | [69] | fitted | |
70 | Virus | rotavirus | CJN strain (unpassaged) | human | healthy 18-45 year old men | oral | symptoms and infection | FFU | [70] | fitted | |
71 | Virus | respiratory syncytial virus | nasal | [71] | not yet in wiki | ||||||
72 | Virus | respiratory syncytial virus | ocular | [72] | not yet in wiki | ||||||
73 | Virus | respiratory syncytial virus | oral | [73] | not fittable | ||||||
74 | Virus | respiratory syncytial virus | [74] | not fittable | |||||||
75 | Virus | respiratory syncytial virus | attenuated | [75] | not fittable | ||||||
76 | Virus | rubella virus | [76] | not fittable | |||||||
77 | Bacterium | Salmonella typhosa | [77] | not fittable | |||||||
78 | Bacterium | Salmonella typhosa | Quailes | human | prisoners | oral (in milk) | disease | CFU | [78] | fitted | |
79 | Bacterium | Salmonella typhosa | Quailes | human | prisoners | oral (in milk) | disease | CFU | [79] | fitted | |
80 | Bacterium | Shigella dysenteriae | M 131 | human | young adult male prisoners | oral (in milk) | illness | organisms | [80] | fitted | |
81 | Bacterium | Shigella flexneri | 2a (strain 2457T) | human | healthy male prisoners | oral (in milk) | illness | CFU | [81] | fitted | |
82 | Bacterium | Shigella flexneri | 2a (strain 2457T) | human | healthy male prisoners | oral (in milk) | positive stool isolation | CFU | [82] | fitted | |
83 | Bacterium | Bacillus anthracis | Vollum | guinea pig | inhalation | death | spores | [83] | fitted | ||
84 | Bacterium | Bacillus anthracis | ATCC 6605 | guinea pig | inhalation | death | spores | [84] | fitted | ||
85 | Bacterium | Bacillus anthracis | Vollum | monkey | rhesus | inhalation | death | spores | [85] | fitted | |
86 | Bacterium | Bacillus anthracis | Vollum | guinea pig | inhalation | death | spores | [86] | fitted | ||
87 | Bacterium | Escherichia coli | ETEC O55 (in paper as “type 55, B5”) | human | male prisoner | oral | moderate to severe illness | organisms | [87] | not fittable | |
88 | Bacterium | Escherichia coli | ETEC O111 (in paper as “E. coli 111, B4”) | human | male prisoner | oral | moderate to severe illness | organisms | [88] | not fittable | |
89 | Protozoan | Aeromonas hydrophila | 6Y | human | healthy adult volunteer | oral | shedding in feces | CFU | [89] | not fittable | |
90 | Protozoan | Aeromonas hydrophila | 6Y | human | healthy adult volunteer | oral | diarrhea | CFU | [90] | not fittable | |
91 | Protozoan | Aeromonas hydrophila | 3647 | human | healthy adult volunteer | oral | shedding in feces | CFU | [91] | not fittable | |
92 | Protozoan | Aeromonas hydrophila | 3647 | human | healthy adult volunteer | oral | diarrhea | CFU | [92] | not fittable | |
93 | Protozoan | Aeromonas hydrophila | B158, SSU, & 3284 | human | healthy adult volunteer | oral | shedding in feces | CFU | [93] | not fittable | |
94 | Protozoan | Aeromonas hydrophila | B158, SSU, & 3284 | human | healthy adult volunteer | oral | diarrhea | CFU | [94] | not fittable | |
95 | Bacterium | Escherichia coli | ETEC B7A | human | male prisoner | oral (in milk) | positive stool isolation | cells | [95] | pooled | |
96 | Bacterium | Escherichia coli | EIEC 4608 | human | male prisoner | oral (in milk) | positive stool isolation | cells | [96] | not fittable | |
97 | Bacterium | Escherichia coli | EIEC 1624 | human | male prisoner | oral (in milk) | positive stool isolation | cells | [97] | fitted | |
98 | Bacterium | Escherichia coli | ETEC B2C | human | male prisoner | oral (in milk) | mild to severe diarrhea | cells | [98] | pooled | |
99 | Bacterium | Escherichia coli | ETEC B2C | human | male prisoner | oral (in milk) | positive stool isolation | cells | [99] | pooled | |
100 | Bacterium | Escherichia coli | HS (nonenteropathogenic) | human | male prisoner | oral (in milk) | mild to severe diarrhea | cells | [100] | not fittable | |
101 | Bacterium | Escherichia coli | HS (nonenteropathogenic) | human | male prisoner | oral (in milk) | positive stool isolation | cells | [101] | not fittable | |
102 | Bacterium | Pseudomonas aeruginosa | human | 29-35 year old lab workers | oral | positive stool isolation | CFU | [102] | not fittable | ||
103 | Bacterium | Salmonella enterica | serovar meleagridis, strain III | human | male prisoner | oral | positive stool isolation | organisms | [103] | not yet in wiki | |
104 | Bacterium | Salmonella enterica | serovar meleagridis, strain III | human | male prisoner | oral | infection | organisms | [104] | not yet in wiki | |
105 | Bacterium | Campylobacter jejuni | strain A3249 | human | young adult | oral (in milk) | infection | CFU | [105] | fitted | |
106 | Bacterium | Campylobacter jejuni | strain A3249 | human | young adult | oral (in milk) | fever, vomiting, or diarrhea | CFU | [106] | not fittable | |
107 | Bacterium | Cryptosporidium parvum | Iowa strain | human | healthy university students & staff | oral | infection | oocysts | [107] | fitted | |
108 | Bacterium | Cryptosporidium parvum | Iowa strain | human | healthy university students & staff | oral | infection and enteric symptoms | oocysts | [108] | not fittable | |
109 | Virus | poliovirus | 1 (Sabin) | infection | [109] | not yet in wiki | |||||
110 | Virus | poliovirus | 3 (Fox) | infection | [110] | not fittable | |||||
111 | Virus | echovirus | 12 | human | [111] | not fittable | |||||
112 | Virus | coxsackievirus | B4 | mouse | newborn | aerosol | death | intraperitoneal LD50 / 0.03 mL | [112] | not fittable | |
113 | Virus | coxsackievirus | A21 (49882 HEK1) | human | healthy adult males | aerosol | infection | TCID50 doses | [113] | not yet in wiki | |
114 | Virus | coxsackievirus | A21 (49882 HEK1) | human | healthy adult males | aerosol | illness | TCID50 doses | [114] | not fittable | |
115 | Virus | coxsackievirus | A21 (48654 HEF2) | human | healthy adult males | aerosol | infection | TCID50 doses | [115] | not yet in wiki | |
116 | Virus | coxsackievirus | A21 (48654 HEF2) | human | healthy adult males | aerosol | illness | TCID50 doses | [116] | not fittable | |
117 | Virus | coxsackievirus | A21 | human | healthy adult male prisoners | 0.3-2.5 micron aerosol | illness | TCID50 doses | [117] | not yet in wiki | |
118 | Virus | coxsackievirus | A21 | human | no antibody | healthy adult male prisoners | combined aerosol and nasal | illness | TCID50 doses | [118] | not fittable |
119 | Virus | coxsackievirus | A21 | human | intermediate antibody | healthy adult male prisoners | combined aerosol and nasal | illness | TCID50 doses | [119] | not fittable |
120 | Virus | coxsackievirus | A21 | human | high antibody | healthy adult male prisoners | combined aerosol and nasal | illness | TCID50 doses | [120] | not fittable |
121 | Virus | coxsackievirus | A21 | human | no antibody | healthy adult male prisoners | combined aerosol and nasal | infection | TCID50 doses | [121] | not fittable |
122 | Virus | coxsackievirus | A21 | human | intermediate antibody | healthy adult male prisoners | combined aerosol and nasal | infection | TCID50 doses | [122] | not fittable |
123 | Virus | coxsackievirus | A21 | human | high antibody | healthy adult male prisoners | combined aerosol and nasal | infection | TCID50 doses | [123] | not fittable |
124 | Virus | rotavirus | CJN strain (unpassaged) | human | healthy 18-45 year old men | oral | detectable shedding | FFU | [124] | fitted | |
125 | Bacterium | Vibrio cholerae | Inaba 569B | human | adult male prisoners | oral (w. NaHCO3) | any diarrhea | CFU | [125] | fitted | |
126 | Bacterium | Vibrio cholerae | Inaba 569B | human | adult male prisoners | oral (w. NaHCO3) | ordinary diarrhea | CFU | [126] | not fittable | |
127 | Bacterium | Vibrio cholerae | Inaba 569B | human | adult male prisoners | oral (w. NaHCO3) | cholera diarrhea | CFU | [127] | fitted | |
128 | Bacterium | Salmonella enterica | serovar meleagridis, strain II | human | male prisoner | oral | positive stool isolation | organisms | [128] | not yet in wiki | |
129 | Bacterium | Salmonella enterica | serovar meleagridis, strain I | human | male prisoner | oral | positive stool isolation | organisms | [129] | not yet in wiki | |
130 | Bacterium | Salmonella enterica | serovar meleagridis, strain I | human | male prisoner | oral | infection | organisms | [130] | not yet in wiki | |
131 | Bacterium | Salmonella enterica | serovar anatum, strain I | human | male prisoner | oral | positive stool isolation | organisms | [131] | not yet in wiki | |
132 | Bacterium | Salmonella enterica | serovar anatum, strain I | human | male prisoner | oral | infection | organisms | [132] | not fittable | |
133 | Bacterium | Salmonella enterica | serovar anatum, strain I | human | male prisoner | oral | positive stool isolation | organisms | [133] | not fittable | |
134 | Bacterium | Salmonella enterica | serovar anatum, strain I | human | male prisoner | oral | positive stool isolation | organisms | [134] | not yet in wiki | |
135 | Bacterium | Salmonella enterica | serovar anatum, strain I | human | male prisoner | oral | infection | organisms | [135] | not fittable | |
136 | Bacterium | Campylobacter jejuni | strain 81-176 | human | young adult | oral (in milk) | infection | CFU | [136] | not yet in wiki | |
137 | Bacterium | Campylobacter jejuni | strain 81-176 | human | young adult | oral (in milk) | diarrhea or fever | CFU | [137] | not fittable | |
138 | Protozoan | Cryptosporidium parvum | Iowa isolate | human | healthy adults | oral | infection | oocysts | [138] | fitted | |
139 | Protozoan | Cryptosporidium parvum | TAMU isolate | human | healthy adults | oral | infection | oocysts | [139] | fitted | |
140 | Protozoan | Cryptosporidium parvum | UCP isolate | human | healthy adults | oral | infection | oocysts | [140] | fitted | |
141 | Bacterium | Escherichia coli | ETEC B7A | human | healthy adults | oral (w. NaHCO3) | diarrhea | CFU | [141] | pooled | |
142 | Bacterium | Escherichia coli | ETEC H10407 (ST< O78:H11) | human | healthy adults | oral (w. NaHCO3) | diarrhea | CFU | [142] | pooled | |
143 | Bacterium | Escherichia coli | ETEC H10407 (ST< O78:H11) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | CFU | [143] | pooled | |
144 | Bacterium | Escherichia coli | ETEC B7A (O148:H28) | human | healthy adults | oral (w. 3g NaHCO3) | diarrhea | organisms | [144] | pooled | |
145 | Bacterium | Escherichia coli | ETEC B7A (O148:H28) | human | healthy adults | oral (w. 3g NaHCO3) | positive stool culture | organisms | [145] | not fittable | |
146 | Bacterium | Escherichia coli | ETEC B7A (O148:H28) | human | healthy adults | oral (w. 3g NaHCO3) | diarrhea | organisms | [146] | pooled | |
147 | Bacterium | Escherichia coli | ETEC B7A (O148:H28) | human | healthy adults | oral (w. 3g NaHCO3) | positive stool culture | organisms | [147] | not fittable | |
148 | Bacterium | Escherichia coli | ETEC B7A (O148:H28) | human | healthy adults | oral (w. 3g NaHCO3) | diarrhea | organisms | [148] | not fittable | |
149 | Bacterium | Escherichia coli | ETEC B7A (O148:H28) | human | healthy adults | oral (w. 3g NaHCO3) | positive stool culture | organisms | [149] | not fittable | |
150 | Bacterium | Escherichia coli | ETEC E2528-C1 (O25:NM) | human | healthy adults | oral (w. 3g NaHCO3) | diarrhea | organisms | [150] | pooled | |
151 | Bacterium | Escherichia coli | ETEC E2528-C1 (O25:NM) | human | healthy adults | oral (w. 3g NaHCO3) | positive stool culture | organisms | [151] | not fittable | |
152 | Bacterium | Escherichia coli | EPEC E2348/69 (O127:H6) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | CFU | [152] | pooled | |
153 | Bacterium | Escherichia coli | EPEC E2348/69 (O127:H6) | human | healthy adults | oral (w. 2g NaHCO3) | shedding in feces | CFU | [153] | pooled | |
154 | Bacterium | Escherichia coli | EPEC 2362-75 (O55:H6) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | CFU | [154] | not fittable | |
155 | Bacterium | Escherichia coli | EPEC 2362-75 (O55:H6) | human | healthy adults | oral (w. 2g NaHCO3) | positive stool culture | CFU | [155] | pooled | |
156 | Bacterium | Escherichia coli | EPEC E2348/69 (O127:H6) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | CFU | [156] | pooled | |
157 | Bacterium | Escherichia coli | EPEC E2348/69 (O127:H6) | human | healthy adults | oral (w. 2g NaHCO3) | positive stool culture | CFU | [157] | pooled | |
158 | Bacterium | Escherichia coli | EPEC E2348/69 (O127:H6) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | CFU | [158] | pooled | |
159 | Bacterium | Escherichia coli | EPEC E2348/69 (O127:H6) | human | healthy adults | oral (w. 2g NaHCO3) | positive stool culture | CFU | [159] | pooled | |
160 | Bacterium | Escherichia coli | ETEC 214-4 (ST) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | organisms | [160] | pooled | |
161 | Bacterium | Escherichia coli | ETEC TD225-C4 (LT) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | organisms | [161] | pooled | |
162 | Bacterium | Escherichia coli | ETEC H10407 (ST< O78:H11) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | organisms | [162] | pooled | |
163 | Bacterium | Escherichia coli | ETEC B7A (ST< O148:H28) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | organisms | [163] | pooled | |
164 | Bacterium | Escherichia coli | ETEC 214-4 (ST) | human | healthy adults | oral (in milk) | diarrhea or vomiting | organisms | [164] | fitted | |
165 | Bacterium | Escherichia coli | ETEC 214-4 (ST) | human | healthy adults | oral (in milk) | positive stool culture | organisms | [165] | fitted | |
166 | Bacterium | Vibrio cholerae | Inaba 569B (classical) | human | adult male prisoners | oral (no NaHCO3) | diarrhea and culture positive | CFU | [166] | fitted | |
167 | Bacterium | Escherichia coli | ETEC H10407 (ST< O78:H11) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | organisms | [167] | pooled | |
168 | Bacterium | Escherichia coli | ETEC B7A (ST< O148:H28) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | organisms | [168] | pooled | |
169 | Bacterium | Escherichia coli | ETEC H10407 (ST< O78:H11) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | organisms | [169] | pooled | |
170 | Bacterium | Escherichia coli | ETEC H10407 (ST< O78:H11) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | organisms | [170] | not fittable | |
171 | Bacterium | Escherichia coli | ETEC 214-4 (ST) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | organisms | [171] | pooled | |
172 | Virus | norovirus | 8fIIa (aggregated virions) | human | positive secretor status (Se+) | oral | infection (shedding & seroconversion) | genomes | [172] | not yet in wiki | |
173 | Virus | norovirus | 8fIIb (dispersed virions) | human | positive secretor status (Se+) | oral | infection (shedding & seroconversion) | genomes | [173] | not yet in wiki | |
174 | Virus | norovirus | 8fIIa (aggregated virions) | human | positive secretor status (Se+) | oral | diarrhea/vomiting | genomes | [174] | not yet in wiki | |
175 | Virus | norovirus | 8fIIb (dispersed virions) | human | positive secretor status (Se+) | oral | diarrhea/vomiting | genomes | [175] | not fittable | |
176 | Bacterium | Escherichia coli | EHEC UC741 (O157:H7) | rabbit | 3 day old | intragastric (w. NaHCO3) | diarrhea | CFU | [176] | fitted | |
177 | Bacterium | Escherichia coli | EHEC UC741 (O157:H7) | rabbit | 3 day old | intragastric (w. NaHCO3) | severe diarrhea | CFU | [177] | not yet in wiki | |
178 | Bacterium | Escherichia coli | EHEC UC741 (O157:H7) | rabbit | 3 day old | intragastric (w. NaHCO3) | death | CFU | [178] | not yet in wiki | |
179 | Protozoan | Cryptosporidium hominis | TU502 | human | healthy adults | oral | infection | oocysts | [179] | not fittable | |
180 | Protozoan | Cryptosporidium hominis | TU502 | human | healthy adults | oral | diarrhea | oocysts | [180] | fitted | |
181 | Protozoan | Cryptosporidium parvum | Moredun isolate | human | healthy adults | oral | diarrhea | oocysts | [181] | not fittable | |
182 | Protozoan | Cryptosporidium parvum | Moredun isolate | human | healthy adults | oral | infection | oocysts | [182] | fitted | |
183 | Bacterium | Campylobacter jejuni | type strain for serotype PEN 1 | mouse | HA-ICR | adult female | intragastric | infection | CFU | [183] | fitted |
184 | Bacterium | Campylobacter jejuni | type strain for serotype PEN 2 | mouse | HA-ICR | adult female | intragastric | infection | CFU | [184] | fitted |
185 | Bacterium | Campylobacter jejuni | type strain for serotype PEN 3 | mouse | HA-ICR | adult female | intragastric | infection | CFU | [185] | fitted |
186 | Bacterium | Campylobacter jejuni | strain CG8421 | human | healthy adults | oral (w. bicarbonate) | campylobacteriosis | CFU | [186] | not fittable | |
187 | Bacterium | Campylobacter jejuni | strain 81-176 | human | healthy adults | oral (w. 2g NaHCO3) | campylobacteriosis | CFU | [187] | fitted | |
188 | Bacterium | Campylobacter jejuni | strain A3249 | human | young adult | oral (in milk) | infection | CFU | [188] | not yet in wiki | |
189 | Bacterium | Campylobacter jejuni | strain A3249 | human | young adult | oral (in milk) | diarrhea or fever | CFU | [189] | not fittable | |
190 | Bacterium | Campylobacter jejuni | strain 480 | chicken | Wickham | shedding in feces | CFU | [190] | not yet in wiki | ||
191 | Bacterium | Campylobacter jejuni | strain 466 | chicken | Lohmann | shedding in feces | CFU | [191] | not fittable | ||
192 | Bacterium | Campylobacter jejuni | strain P5444 | chicken | Lohmann | shedding in feces | CFU | [192] | not fittable | ||
193 | Bacterium | Campylobacter jejuni | strain P5623 | chicken | Lohmann | shedding in feces | CFU | [193] | not fittable | ||
194 | Bacterium | Campylobacter jejuni | strain 119a | chicken | Lohmann | shedding in feces | CFU | [194] | not fittable | ||
195 | Bacterium | Campylobacter jejuni | strain 121a | chicken | Lohmann | shedding in feces | CFU | [195] | not fittable | ||
196 | Bacterium | Campylobacter jejuni | strain 123a | chicken | Lohmann | shedding in feces | CFU | [196] | not fittable | ||
197 | Bacterium | Campylobacter coli | UA585 | chicken | Wickham | shedding in feces | CFU | [197] | not fittable | ||
198 | Bacterium | Campylobacter jejuni | strain 93/146 | chicken | Wickham | shedding in feces | CFU | [198] | not fittable | ||
199 | Bacterium | Campylobacter jejuni | strain 94/146 | chicken | Wickham | shedding in feces | CFU | [199] | not fittable | ||
200 | Bacterium | Campylobacter jejuni | strain 93175 | chicken | Wickham | shedding in feces | CFU | [200] | not fittable | ||
201 | Bacterium | Campylobacter jejuni | strain 0087 | chicken | Lohmann | shedding in feces | CFU | [201] | not yet in wiki | ||
202 | Bacterium | Campylobacter jejuni | strain 81116P | chicken | Wickham | shedding in feces | CFU | [202] | not yet in wiki | ||
203 | Bacterium | Campylobacter jejuni | strain R3P | chicken | Wickham | shedding in feces | CFU | [203] | not fittable | ||
204 | Bacterium | Campylobacter jejuni | strain 81-176 | chicken | Wickham | shedding in feces | CFU | [204] | not fittable | ||
205 | Bacterium | Campylobacter jejuni | strain 81-176 | chicken | Lohmann | shedding in feces | CFU | [205] | not fittable | ||
206 | Bacterium | Campylobacter jejuni | strain 11168 | chicken | Wickham | shedding in feces | CFU | [206] | not fittable | ||
207 | Bacterium | Campylobacter jejuni | strain 11168 | chicken | Lohmann | shedding in feces | CFU | [207] | not yet in wiki | ||
208 | Bacterium | Campylobacter jejuni | strain R3 | chicken | Wickham | shedding in feces | CFU | [208] | not fittable | ||
209 | Bacterium | Campylobacter jejuni | strain 81116 | chicken | Wickham | shedding in feces | CFU | [209] | not yet in wiki | ||
210 | Bacterium | Campylobacter jejuni | strain 81116 | chicken | Lohmann | shedding in feces | CFU | [210] | not yet in wiki | ||
211 | Bacterium | Campylobacter jejuni | strain 81117 | chicken | Lohmann | shedding in feces | CFU | [211] | fitted | ||
212 | Bacterium | Escherichia coli | EHEC O157:H7, strain 86-24 | pig | 3 month old | oral (in food) | shedding in feces | CFU | [212] | fitted | |
213 | Bacterium | Escherichia coli | EPEC B171-8 (serotype O11:NM) | human | healthy adults | oral (w. NaHCO3) | diarrhea | CFU | [213] | pooled | |
214 | Bacterium | Shigella dysenteriae | A-1 | human | young adult male prisoners | oral (in milk) | illness | organisms | [214] | pooled | |
215 | Bacterium | Escherichia coli | EPEC E2348/69 (O127:H6) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | CFU | [215] | pooled | |
216 | Bacterium | Escherichia coli | EPEC E851/71 (O142:H6) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | CFU | [216] | pooled | |
217 | Bacterium | Escherichia coli | EPEC E74/68 (O128:H2) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | CFU | [217] | not fittable | |
218 | Bacterium | Escherichia coli | EPEC E2348/69 (O127:H6) | human | healthy adults | oral (w. 2g NaHCO3) | positive stool culture | CFU | [218] | pooled | |
219 | Bacterium | Escherichia coli | EPEC E851/71 (O142:H6) | human | healthy adults | oral (w. 2g NaHCO3) | positive stool culture | CFU | [219] | pooled | |
220 | Bacterium | Escherichia coli | EPEC E74/68 (O128:H2) | human | healthy adults | oral (w. 2g NaHCO3) | positive stool culture | CFU | [220] | pooled | |
221 | Bacterium | Escherichia coli | ETEC H10407 (O78:H11) | human | healthy adults | oral (w. 2g NaHCO3) | diarrhea | CFU | [221] | not fittable | |
222 | Bacterium | Shigella flexneri | 2a (strain 2457T) | human | healthy male prisoners | oral (in milk) | illness | CFU | [222] | fitted | |
223 | Bacterium | Shigella sonnei | 53G | human | healthy male prisoners | oral (in milk) | illness | CFU | [223] | pooled | |
224 | Bacterium | Shigella sonnei | 53G | human | healthy male prisoners | oral (in milk) | illness | CFU | [224] | pooled | |
225 | Bacterium | Campylobacter jejuni | strain A3249 | human | young adult | oral (w. 2g NaHCO3) | infection | CFU | [225] | not fittable | |
226 | Bacterium | Escherichia coli | O157 | human | oral | illness | organisms (estimated) | [226] | not fittable | ||
227 | Virus | rotavirus | rhesus rotavirus vaccine serotype 3 | human | infants aged 2-5 months | oral (w. buffer) | seroconversion | PFU | [227] | not yet in wiki | |
228 | Virus | rotavirus | rhesus rotavirus vaccine serotype 3 | human | infants aged 2-5 months | oral (w/o buffer) | seroconversion | PFU | [228] | not yet in wiki | |
229 | Virus | rotavirus | rhesus rotavirus vaccine serotype 3 | human | infants aged 2-5 months | oral (exclusively breastfed) | seroconversion | PFU | [229] | not fittable | |
230 | Virus | rotavirus | rhesus rotavirus vaccine serotype 3 | human | infants aged 2-5 months | oral (not exclusively breastfed) | seroconversion | PFU | [230] | not yet in wiki | |
231 | Bacterium | Salmonella anatum | strain I | human | healthy men | oral (w. eggnog) | positive stool culture | organisms | [231] | fitted | |
232 | Bacterium | Salmonella anatum | strain II | human | healthy men | oral (w. eggnog) | positive stool culture | organisms | [232] | fitted | |
233 | Bacterium | Salmonella anatum | strain III | human | healthy men | oral (w. eggnog) | positive stool culture | organisms | [233] | not yet in wiki | |
234 | Bacterium | Salmonella newport | human | human volunteers | oral | organisms | [234] | fitted | |||
235 | Bacterium | Salmonella derby | human | human volunteers | oral | organisms | [235] | not fittable | |||
236 | Bacterium | Salmonella bareily | human | human volunteers | oral | organisms | [236] | not fittable | |||
237 | Bacterium | Salmonella meleagridis | strain I | human | human volunteers | oral (w. eggnog) | organisms | [237] | fitted | ||
238 | Bacterium | Salmonella meleagridis | strain II | human | human volunteers | oral (w. eggnog) | organisms | [238] | not fittable | ||
239 | Bacterium | Salmonella meleagridis | strain III | human | human volunteers | oral (w. eggnog) | organisms | [239] | fitted | ||
240 | Bacterium | Legionella | Philadelphia 1 | guinea pig | inhalation | Infection | CFU | [240] | fitted | ||
241 | Bacterium | Legionella | strain 74/81 | mice | inhalation | death | CFU | [241] | fitted | ||
242 | Bacterium | Legionella | Philadelphia 1 | guinea pig | inhalation | death | CFU | [242] | fitted | ||
243 | Bacterium | Rickettsia rickettsi | rhesus macaques | aerosol | death | organisms | [243] | fitted | |||
244 | Bacterium | Rickettsia rickettsi | KHW | mice | intravenous | infection | organisms | [244] | fitted | ||
245 | Bacterium | Salmonella nontyphoid | strain 216 and 219 | mice | intraperitoneal | death | organisms | [245] | fitted | ||
246 | Bacterium | Salmonella nontyphoid | strain 533 | mice | intraperitoneal | death | organisms | [246] | fitted | ||
247 | Bacterium | Salmonella nontyphoid | strain 533 | mice | intraperitoneal | death | organisms | [247] | fitted | ||
248 | Bacterium | Vibrio cholerae | Inaba 569 B | human | oral (w. NaHCO3) | Infection | CFU | [248] | fitted | ||
249 | Prion | Prion | scrapie strain 263k | hamsters | oral | death | LD50 i.c. | [249] | fitted | ||
250 | Prion | Prion | scrapie strain C506M3 | mice | intraperitoneal | death | LD50 i.c. | [250] | fitted | ||
251 | Prion | Prion | BSE agent | mice | unknown type of injection | Infection | ID50 unit | [251] | fitted | ||
252 | Protozoan | Naegleria fowleri | LEE strain | mice | intravenous | death | organism | [252] | fitted | ||
253 | Protozoan | Naegleria fowleri | LEE strain | mice | intravenous | death | organism | [253] | fitted | ||
254 | Virus | adenovirus | type 4 | human | intranasal | infection | TICD50 | [254] | fitted | ||
255 | Virus | echovirus | 12 | human | [255] | fitted | |||||
256 | Virus | Influenza | H1N1,A/California/10/78 attenuated strain | human | intranasal | infection | TCID50 | [256] | fitted | ||
257 | Virus | Influenza | H3N2,A/Washington/897/80 attenuated strain | human | intranasal | infection | TCID50 | [257] | fitted | ||
258 | Virus | Influenza | H5N1, DKGX/35 strain | mice | intranasal | death | EID50 | [258] | fitted | ||
259 | Virus | SARS | rSARS-CoV | mice | intranasal | death | PFU | [259] | fitted | ||
260 | Virus | SARS | MHV-1 | mice | intranasal | death | PFU | [260] | fitted | ||
261 | Bacterium | Mycobacterium avium | sub sp. Paratuberculosis Bovine | deer | 4 month old red deer | oral | infection | CFU | [261] | fitted | |
262 | Bacterium | Mycobacterium avium | sub sp. Paratuberculosis IOI strain | cheviots | South Country | oral | infection | CFU | [262] | fitted | |
263 | Protozoan | Acanthamoeba | Ac118 | rat | eyes (cornea) | infection | orgnanism | [263] | fitted | ||
264 | Protozoan | Acanthamoeba | Ac119 | rat | eyes (cornea) | infection | orgnanism | [264] | fitted | ||
265 | Protozoan | Acanthamoeba | mice | intranasal | death | orgnanism | [265] | not yet in wiki | |||
266 | Protozoan | Acanthamoeba | guinea pig | intracardial | death | orgnanism | [266] | not yet in wiki | |||
267 | Protozoan | Acanthamoeba | mice | intracerebral | death | orgnanism | [267] | not yet in wiki | |||
268 | Protozoan | Acanthamoeba | guinea pig | intracerebral | death | orgnanism | [268] | not fittable | |||
269 | Protozoan | Acanthamoeba | mice | intranasal | death | orgnanism | [269] | fitted | |||
270 | Protozoan | Acanthamoeba | mice | intranasal | brain invasion | orgnanism | [270] | fitted | |||
271 | Protozoan | Acanthamoeba | mice | intranasal | acute meningoencephalitis | orgnanism | [271] | fitted | |||
272 | Protozoan | Acanthamoeba | mice | intranasal | Granulotomous Encephalitis | orgnanism | [272] | not fittable | |||
273 | Bacterium | Francisella tularensis | SCHU S-4 | monkeys | inhalation | death | organism | [273] | fitted | ||
274 | Bacterium | Francisella tularensis | Aa strain | mice | oral | death | organism | [274] | fitted | ||
275 | Protozoan | Naegleria fowleri | Lee | mice | CD 1 | intranasal (swimming) | death | organisms | [275] | not yet in wiki | |
276 | Protozoan | Naegleria fowleri | Lee | mice | CD 1 | intranasal (swimming) | death | organisms | [276] | not yet in wiki | |
277 | Bacterium | Staphylococcus ayreus | human | subcutaneous | infection | organisms | [277] | fitted | |||
278 | Bacterium | Pseudomonas aeruginosa | rabbits | contact lens | corneal ulceration | CFU/ml | [278] | fitted | |||
279 | Bacterium | Pseudomonas aeruginosa | rabbits | contact lens | severe stromal ulceration | CFU/ml | [279] | fitted | |||
280 | Bacterium | Pseudomonas aeruginosa | ATCC 19660 | mice | Swiss -Webster | 5 day old | injected (eyelids) | death | CFU | [280] | fitted |
281 | Bacterium | Pseudomonas aeruginosa | ATCC 19660 | mice | Swiss -Webster | 5 day old | injected (eyelids) | death | CFU | [281] | fitted |
282 | Bacterium | Pseudomonas aeruginosa | ATCC 19660 | mice | Swiss -Webster | 10 day old | injected (eyelids) | death | CFU | [282] | fitted |
283 | Bacterium | Pseudomonas aeruginosa | ATCC 19660 | mice | Swiss -Webster | 10 day old | injected (eyelids) | death | CFU | [283] | fitted |
284 | Bacterium | Pseudomonas aeruginosa | ATCC 19660 | mice | Swiss -Webster | 10 day old | injected (eyelids) | death | CFU | [284] | not yet in wiki |
285 | Bacterium | Pseudomonas aeruginosa | ATCC 19660 | mice | Swiss -Webster | 15-16 day old | injected (cornea) | infection (Keratitis) | CFU | [285] | fitted |
286 | Bacterium | Pseudomonas aeruginosa | ATCC 19660 | mice | Swiss -Webster | 21 day old | injected (cornea) | infection (cataract) | CFU | [286] | not fittable |
287 | Bacterium | Pseudomonas aeruginosa | ATCC 19660 | mice | Swiss -Webster | 21 day old | injected (cornea) | infection (Keratitis) | CFU | [287] | not fittable |
288 | Bacterium | Listeria monocytogenes | rhesus monkeys | pregnant | oral | stillbirths | CFU | [288] | fitted | ||
289 | Bacterium | Listeria monocytogenes | mice | pregnant | oral | infected fetuses | CFU | [289] | fitted | ||
290 | Bacterium | Listeria monocytogenes | mice | oral | death | CFU | [290] | fitted | |||
291 | Bacterium | Listeria monocytogenes | mice | oral | infection | CFU | [291] | fitted | |||
292 | Bacterium | Listeria monocytogenes | Scott A | mice | A/J mice | intragastric | death | CFU | [292] | fitted | |
293 | Bacterium | Listeria monocytogenes | Scott A | mice | C57BL/6 | intragastric | death | CFU | [293] | fitted | |
294 | Bacterium | Listeria monocytogenes | F5817 | mice | C57Bl/6J | oral | infection | CFU | [294] | fitted | |
295 | Bacterium | Listeria monocytogenes | strain 10401 | mice | OF1 female | oral | infection | CFU | [295] | fitted | |
296 | Bacterium | Pseudomonas aeruginosa | rabbit | contact lens | corneal ulceration | CFU | [296] | fitted | |||
297 | Bacterium | Pseudomonas aeruginosa | rabbit | contact lens | Severe stromal ulceration | CFU | [297] | fitted |
References
- ↑ Lathem WW, Crosby SD, Miller VL and Goldman WE (2005) Progression of primary pneumonic plague: A mouse model of infection, pathology, and bacterial transcriptional activity. Proceedings of the National Academy of Sciences of the United States of America. 102 (49), 17786–17791.
- ↑ Parent MA, Berggren KN, Kummer LW, Wilhelm LB, Szaba FM, Mullarky IK and Smiley ST (2005) Cell-Mediated Protection against Pulmonary Yersinia pestis Infection. Infection and Immunity. 73 (11), 7304–7310.
- ↑ Rogers JV, Choi YW, Giannunzio LF, Sabourin PJ, Bornman DM, Blosser EG and Sabourin CLK (2007) Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92. Microbial Pathogenesis. 43 (2–3), 67–77.
- ↑ Chen TH, Foster LE and Meyer KF (1974) Comparison of the Immune Response to Three Different Yersinia pestis Vaccines in Guinea Pigs and Langurs. Journal of Infectious Diseases. 129 (Supplement 1), S53–S61.
- ↑ Chen TH, Foster LE and Meyer KF (1974) Comparison of the Immune Response to Three Different Yersinia pestis Vaccines in Guinea Pigs and Langurs. Journal of Infectious Diseases. 129 (Supplement 1), S53–S61.
- ↑ Chen TH, Foster LE and Meyer KF (1974) Comparison of the Immune Response to Three Different Yersinia pestis Vaccines in Guinea Pigs and Langurs. Journal of Infectious Diseases. 129 (Supplement 1), S53–S61.
- ↑ SPECK RS and WOLOCHOW H (1957) Studies on the experimental epidemiology of respiratory infections. VIII. Experimental pneumonic plague in Macacus rhesus. The Journal of infectious diseases. 100 (1), 58–69.
- ↑ HOLDENRIED R and QUAN SF (1956) Susceptibility of New Mexico rodents to experimental plague. Public health reports. 71 (10), 979–984.
- ↑ Marshall RG and Gerone PJ (1961) SUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS. Journal of Bacteriology. 82 (1), 15–19.
- ↑ Marshall RG and Gerone PJ (1961) SUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS. Journal of Bacteriology. 82 (1), 15–19.
- ↑ Marshall RG and Gerone PJ (1961) SUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS. Journal of Bacteriology. 82 (1), 15–19.
- ↑ Marshall RG and Gerone PJ (1961) SUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS. Journal of Bacteriology. 82 (1), 15–19.
- ↑ Jahrling PB, Smith S, Hesse RA and Rhoderick JB (1982) Pathogenesis of Lassa virus infection in guinea pigs. Infection and Immunity. 37 (2), 771–778.
- ↑ Jahrling PB, Smith S, Hesse RA and Rhoderick JB (1982) Pathogenesis of Lassa virus infection in guinea pigs. Infection and Immunity. 37 (2), 771–778.
- ↑ Stephenson EH, Larson EW and Dominik JW (1984) Effect of environmental factors on aerosol-induced Lassa virus infection. Journal of medical virology. 14 (4), 295–303.
- ↑ Stephenson EH, Larson EW and Dominik JW (1984) Effect of environmental factors on aerosol-induced Lassa virus infection. Journal of medical virology. 14 (4), 295–303.
- ↑ Liu B, Koo GC, Yap EH, Chua KL and Gan Y-H (2002) Model of Differential Susceptibility to Mucosal Burkholderia pseudomallei Infection. Infection and Immunity. 70 (2), 504–511.
- ↑ Liu B, Koo GC, Yap EH, Chua KL and Gan Y-H (2002) Model of Differential Susceptibility to Mucosal Burkholderia pseudomallei Infection. Infection and Immunity. 70 (2), 504–511.
- ↑ Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, Chen D, Lipscomb L, Kim HS, Mrázek J, Nierman WC and DeShazer D (2007) Type VI secretion is a major virulence determinant in Burkholderia mallei. Molecular Microbiology. 64 (6), 1466–1485.
- ↑ Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, Chen D, Lipscomb L, Kim HS, Mrázek J, Nierman WC and DeShazer D (2007) Type VI secretion is a major virulence determinant in Burkholderia mallei. Molecular Microbiology. 64 (6), 1466–1485.
- ↑ Miller WR, Pannell L, Cravitz L, Tanner WA and Rosebury T (1948) Studies on Certain Biological Characteristics of Malleomyces mallei and Malleomyces pseudomallei. Journal of Bacteriology. 55 (1), 127–135.
- ↑ Miller WR, Pannell L, Cravitz L, Tanner WA and Rosebury T (1948) Studies on Certain Biological Characteristics of Malleomyces mallei and Malleomyces pseudomallei. Journal of Bacteriology. 55 (1), 127–135.
- ↑ Brett PJ and Woods DE (2000) Pathogenesis of and immunity to melioidosis. Acta Tropica. 74 (2–3), 201–210.
- ↑ Russell-Lodrigue KE, Zhang GQ, McMurray DN and Samuel JE (2006) Clinical and Pathologic Changes in a Guinea Pig Aerosol Challenge Model of Acute Q Fever. Infection and Immunity. 74 (11), 6085–6091.
- ↑ Andoh M, Naganawa T, Hotta A, Yamaguchi T, Fukushi H, Masegi T and Hirai K (2003) SCID Mouse Model for Lethal Q Fever. Infection and Immunity. 71 (8), 4717–4723.
- ↑ Scott GH, Williams JC and Stephenson EH (1987) Animal Models in Q Fever: Pathological Responses of Inbred Mice to Phase I Coxiella burnetii. Journal of General Microbiology. 133 (3), 691–700.
- ↑ Scott GH, Williams JC and Stephenson EH (1987) Animal Models in Q Fever: Pathological Responses of Inbred Mice to Phase I Coxiella burnetii. Journal of General Microbiology. 133 (3), 691–700.
- ↑ Williams JC and Cantrell JL (1982) Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice. Infection and Immunity. 35 (3), 1091–1102.
- ↑ BENENSON AS and TIGERTT WD (1956) Studies on Q fever in man. Transactions of the Association of American Physicians. 69, 98–104.
- ↑ Hamory BH, Couch RB, Douglas RG Jr, Black SH and Knight V (1972) Characterization of the infectious unit for man of two respiratory viruses. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 139 (3), 890–893.
- ↑ Couch RB, Cate TR, Douglas RG, Gerone PJ and Knight V (1966) Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriological Reviews. 30 (3), 517–529.
- ↑ Kurtz JB, Lee TW, Craig JW and Reed SE (1979) Astrovirus infection in volunteers. Journal of medical virology. 3 (3), 221–230.
- ↑ Hornick RB, Music SI, Wenzel R, Cash R, Libonati JP, Snyder MJ and Woodward TE (1971) The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bulletin of the New York Academy of Medicine. 47 (10), 1181–1191.
- ↑ Hornick RB, Music SI, Wenzel R, Cash R, Libonati JP, Snyder MJ and Woodward TE (1971) The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bulletin of the New York Academy of Medicine. 47 (10), 1181–1191.
- ↑ Hornick RB, Music SI, Wenzel R, Cash R, Libonati JP, Snyder MJ and Woodward TE (1971) The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bulletin of the New York Academy of Medicine. 47 (10), 1181–1191.
- ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
- ↑ Kotak BG, Kenefick SL, Fritz DL, Rousseaux CG, Prepas EE and Hrudey SE (1993) Occurrence and toxicological evaluation of cyanobacterial toxins in Alberta lakes and farm dugouts. Water Research. 27 (3), 495–506.
- ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
- ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
- ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
- ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
- ↑ JUNE RC, FERGUSON WW and WORFEL MT (1953) Experiments in feeding adult volunteers with Escherichia coli 55, B5, a coliform organism associated with infant diarrhea. American journal of hygiene. 57 (2), 222–236.
- ↑ Feeguson WW and June EC (1952) Experiments on Feeding Adult Volunteers with Escherichia Coli 111, B4, a Coliform Organism Associated with Infant Diarrhea. American Journal of Epidemiology. 55 (2), 155–160.
- ↑ Haas CN, Rose JB and Gerba CP (1999) Quantitative Microbial Risk Assessment. John Wiley and Sons
- ↑ RENDTORFF RC (1954) The experimental transmission of human intestinal protozoan parasites. I. Endamoeba coli cysts given in capsules. American journal of hygiene. 59 (2), 196–208.
- ↑ RENDTORFF RC (1954) The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. American journal of hygiene. 59 (2), 209–220.
- ↑ Erlandsen SL, Sherlock LA, Januschka M, Schupp DG, Schaefer FW, Jakubowski W and Bemrick WJ (1988) Cross-species transmission of Giardia spp.: inoculation of beavers and muskrats with cysts of human, beaver, mouse, and muskrat origin. Applied and Environmental Microbiology. 54 (11), 2777–2785.
- ↑ Erlandsen SL, Sherlock LA, Januschka M, Schupp DG, Schaefer FW, Jakubowski W and Bemrick WJ (1988) Cross-species transmission of Giardia spp.: inoculation of beavers and muskrats with cysts of human, beaver, mouse, and muskrat origin. Applied and Environmental Microbiology. 54 (11), 2777–2785.
- ↑ Istre GR, Dunlop TS, Gaspard GB and Hopkins RS (1984) Waterborne giardiasis at a mountain resort: evidence for acquired immunity. American Journal of Public Health. 74 (6), 602–604.
- ↑ Labatiuk CW, Schaefer FW, Finch GR and Belosevic M (1991) Comparison of animal infectivity, excystation, and fluorogenic dye as measures of Giardia muris cyst inactivation by ozone. Applied and Environmental Microbiology. 57 (11), 3187–3192.
- ↑ WARD R, KRUGMAN S, GILES JP, JACOBS AM and BODANSKY O (1958) Infectious hepatitis; studies of its natural history and prevention. The New England journal of medicine. 258 (9), 407–416.
- ↑ WARD R, KRUGMAN S, GILES JP, JACOBS AM and BODANSKY O (1958) Infectious hepatitis; studies of its natural history and prevention. The New England journal of medicine. 258 (9), 407–416.
- ↑ Taylor-Robinson D and Bynoe ML (1963) Para-influenza 2 virus infections in adult volunteers. The Journal of Hygiene. 61 (4), 407–417.
- ↑ Taylor-Robinson D and Bynoe ML (1963) Para-influenza 2 virus infections in adult volunteers. The Journal of Hygiene. 61 (4), 407–417.
- ↑ CRAIGHEAD JE, COOK MK and CHANOCK RM (1960) Infection of hamsters with para influenza 3 virus. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 104, 301–304.
- ↑ Koprowski H (1956) Immunization against Poliomyelitis with Living Attenuated Virus. The American Journal of Tropical Medicine and Hygiene. 5 (3), 440–452.
- ↑ Minor TE, Allen CI, Tsiatis AA, Nelson DB and D’Alessio DJ (1981) Human infective dose determinations for oral poliovirus type 1 vaccine in infants. Journal of Clinical Microbiology. 13 (2), 388–389.
- ↑ Koprowski H (1956) Immunization against Poliomyelitis with Living Attenuated Virus. The American Journal of Tropical Medicine and Hygiene. 5 (3), 440–452.
- ↑ SABIN AB (1955) Behavior of chimpanzee avirulent poliomyelitis viruses in experimentally infected human volunteers. The American journal of the medical sciences. 230 (1), 1–8.
- ↑ Katz M and Plotkin SA (1967) Minimal infective dose of attenuated poliovirus for man. American Journal of Public Health and the Nations Health. 57 (10), 1837–1840.
- ↑ SABIN AB (1955) Behavior of chimpanzee avirulent poliomyelitis viruses in experimentally infected human volunteers. The American journal of the medical sciences. 230 (1), 1–8.
- ↑ Cliver, D. O. (1981). Experimental infection by waterborne enteroviruses. Journal of Food Protection. 44,861-865.
- ↑ Cliver, D. O. (1981). Experimental infection by waterborne enteroviruses. Journal of Food Protection. 44,861-865.
- ↑ Hendley JO, Edmondson WP and Gwaltney JM (1972) Relation between Naturally Acquired Immunity and Infectivity of Two Rhinoviruses in Volunteers. Journal of Infectious Diseases. 125 (3), 243–248.
- ↑ Hendley JO, Edmondson WP and Gwaltney JM (1972) Relation between Naturally Acquired Immunity and Infectivity of Two Rhinoviruses in Volunteers. Journal of Infectious Diseases. 125 (3), 243–248.
- ↑ Graham DY, Dufour GR and Estes MK (1987) Minimal infective dose of rotavirus. Archives of virology. 92 (3-4), 261–271.
- ↑ Gouvea VS, Alencar AA, Barth OM, Castro L de, Fialho AM, Araújo HP, Majerowicz S and Pereira HG (1986) Diarrhoea in Mice Infected with a Human Rotavirus. Journal of General Virology. 67 (3), 577–581.
- ↑ Payment P and Morin E (1990) Minimal infective dose of the OSU strain of porcine rotavirus. Archives of virology. 112 (3-4), 277–282.
- ↑ Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR and Schiff GM (1986) Human Rotavirus Studies in Volunteers: Determination of Infectious Dose and Serological Response to Infection. Journal of Infectious Diseases. 154 (5), 871–880.
- ↑ Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR and Schiff GM (1986) Human Rotavirus Studies in Volunteers: Determination of Infectious Dose and Serological Response to Infection. Journal of Infectious Diseases. 154 (5), 871–880.
- ↑ Hall CB, Douglas RG, Schnabel KC and Geiman JM (1981) Infectivity of respiratory syncytial virus by various routes of inoculation. Infection and Immunity. 33 (3), 779–783.
- ↑ Hall CB, Douglas RG, Schnabel KC and Geiman JM (1981) Infectivity of respiratory syncytial virus by various routes of inoculation. Infection and Immunity. 33 (3), 779–783.
- ↑ Hall CB, Douglas RG, Schnabel KC and Geiman JM (1981) Infectivity of respiratory syncytial virus by various routes of inoculation. Infection and Immunity. 33 (3), 779–783.
- ↑ Parrott RH, Kim HW, Brandt CD and Chanock RM (1974) Respiratory syncytial virus in infants and children. Preventive medicine. 3 (4), 473–480.
- ↑ Wright PF, Belshe RB, Kim HW, Van Voris LP and Chanock RM (1982) Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infection and Immunity. 37 (1), 397–400.
- ↑ Plotkin SA, Cornfeld D and Ingalls TH (1965) Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus. American journal of diseases of children (1960). 110 (4), 381–389.
- ↑ Feldman RE, Baine WB, Nitzkin JL, Saslaw MS and Pollard RA (1974) Epidemiology of Salmonella typhi Infection in a Migrant Labor Camp in Dade County, Florida. Journal of Infectious Diseases. 130 (4), 334–342.
- ↑ Hornick RB, Woodward TE, McCrumb FR, Snyder MJ, Dawkins AT, Bulkeley JT, De la Macorra F and Corozza FA (1966) Study of induced typhoid fever in man. I. Evaluation of vaccine effectiveness. Transactions of the Association of American Physicians. 79, 361–367.
- ↑ Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT and Snyder MJ (1970) Typhoid fever: pathogenesis and immunologic control. The New England journal of medicine. 283 (13), 686–691.
- ↑ Levine MM, DuPont HL, Formal SB, Hornick RB, Takeuchi A, Gangarosa EJ, Snyder MJ and Libonati JP (1973) Pathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery. Journal of Infectious Diseases. 127 (3), 261–270.
- ↑ DuPont HL, Hornick RB, Dawkins AT, Snyder MJ and Formal SB (1969) The Response of Man to Virulent Shigella flexneri 2a. Journal of Infectious Diseases. 119 (3), 296–299.
- ↑ DuPont HL, Hornick RB, Snyder MJ, Libonati JP, Formal SB and Gangarosa EJ (1972) Immunity in Shigellosis. I. Response of Man to Attenuated Strains of Shigella. Journal of Infectious Diseases. 125 (1), 5–11.
- ↑ Altboum Z, Gozes Y, Barnea A, Pass A, White M and Kobiler D (2002) Postexposure Prophylaxis against Anthrax: Evaluation of Various Treatment Regimens in Intranasally Infected Guinea Pigs. Infection and Immunity. 70 (11), 6231–6241.
- ↑ Altboum Z, Gozes Y, Barnea A, Pass A, White M and Kobiler D (2002) Postexposure Prophylaxis against Anthrax: Evaluation of Various Treatment Regimens in Intranasally Infected Guinea Pigs. Infection and Immunity. 70 (11), 6231–6241.
- ↑ Druett HA, Henderson DW, Packman L and Peacock S (1953) Studies on respiratory infection. The Journal of Hygiene. 51 (3), 359–371.
- ↑ Druett HA, Henderson DW, Packman L and Peacock S (1953) Studies on respiratory infection. The Journal of Hygiene. 51 (3), 359–371.
- ↑ JUNE RC, FERGUSON WW and WORFEL MT (1953) Experiments in feeding adult volunteers with Escherichia coli 55, B5, a coliform organism associated with infant diarrhea. American journal of hygiene. 57 (2), 222–236.
- ↑ Feeguson WW and June EC (1952) Experiments on Feeding Adult Volunteers with Escherichia Coli 111, B4, a Coliform Organism Associated with Infant Diarrhea. American Journal of Epidemiology. 55 (2), 155–160.
- ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
- ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
- ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
- ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
- ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
- ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
- ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
- ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
- ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
- ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
- ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
- ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
- ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
- ↑ Buck AC and Cooke EM (1969) The Fate Of Ingested Pseudomonas Aeruginosa In Normal Persons. Journal of Medical Microbiology. 2 (4), 521–525.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
- ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
- ↑ DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB and Jakubowski W (1995) The infectivity of Cryptosporidium parvum in healthy volunteers. The New England journal of medicine. 332 (13), 855–859.
- ↑ DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB and Jakubowski W (1995) The infectivity of Cryptosporidium parvum in healthy volunteers. The New England journal of medicine. 332 (13), 855–859.
- ↑ LEPOW ML, WARREN RJ, INGRAM VG, DAUGHERTY SC and ROBBINS FC (1962) Sabin type I (LSc2ab) oral poliomyelitis vaccine. Effect of dose upon response of newborn infants. American journal of diseases of children (1960). 104, 67–71.
- ↑ Katz M and Plotkin SA (1967) Minimal infective dose of attenuated poliovirus for man. American Journal of Public Health and the Nations Health. 57 (10), 1837–1840.
- ↑ Schiff GM, Stefanović GM, Young EC, Sander DS, Pennekamp JK and Ward RL (1984) Studies of echovirus-12 in volunteers: determination of minimal infectious dose and the effect of previous infection on infectious dose. The Journal of infectious diseases. 150 (6), 858–866.
- ↑ Suptel, E.A. (1963) Pathogenesis of experimental Coxsackie virus infection. Archive of Virology. 7, 61-66
- ↑ Couch RB, Cate TR, Gerone PJ, Fleet WF, Lang DJ, Griffith WR and Knight V (1965) Production of Illness with a Small-Particle Aerosol of Coxsackie A21*. Journal of Clinical Investigation. 44 (4), 535–542.
- ↑ Couch RB, Cate TR, Gerone PJ, Fleet WF, Lang DJ, Griffith WR and Knight V (1965) Production of Illness with a Small-Particle Aerosol of Coxsackie A21*. Journal of Clinical Investigation. 44 (4), 535–542.
- ↑ Couch RB, Cate TR, Gerone PJ, Fleet WF, Lang DJ, Griffith WR and Knight V (1965) Production of Illness with a Small-Particle Aerosol of Coxsackie A21*. Journal of Clinical Investigation. 44 (4), 535–542.
- ↑ Couch RB, Cate TR, Gerone PJ, Fleet WF, Lang DJ, Griffith WR and Knight V (1965) Production of Illness with a Small-Particle Aerosol of Coxsackie A21*. Journal of Clinical Investigation. 44 (4), 535–542.
- ↑ Couch RB, Knight V, Gerone PJ, Cate TR and Douglas RG (1969) Factors influencing response of volunteers to inoculation with Coxsackie virus A type 21. The American review of respiratory disease. 99 (1), 24–30.
- ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
- ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
- ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
- ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
- ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
- ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
- ↑ Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR and Schiff GM (1986) Human Rotavirus Studies in Volunteers: Determination of Infectious Dose and Serological Response to Infection. Journal of Infectious Diseases. 154 (5), 871–880.
- ↑ Kotak BG, Kenefick SL, Fritz DL, Rousseaux CG, Prepas EE and Hrudey SE (1993) Occurrence and toxicological evaluation of cyanobacterial toxins in Alberta lakes and farm dugouts. Water Research. 27 (3), 495–506.
- ↑ Kotak BG, Kenefick SL, Fritz DL, Rousseaux CG, Prepas EE and Hrudey SE (1993) Occurrence and toxicological evaluation of cyanobacterial toxins in Alberta lakes and farm dugouts. Water Research. 27 (3), 495–506.
- ↑ Kotak BG, Kenefick SL, Fritz DL, Rousseaux CG, Prepas EE and Hrudey SE (1993) Occurrence and toxicological evaluation of cyanobacterial toxins in Alberta lakes and farm dugouts. Water Research. 27 (3), 495–506.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
- ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
- ↑ Messner MJ, Chappell CL and Okhuysen PC (2001) Risk Assessment for Cryptosporidium: A Hierarchical Bayesian Analysis of Human Dose Response Data. Water Research. 35 (16), 3934–3940.
- ↑ Messner MJ, Chappell CL and Okhuysen PC (2001) Risk Assessment for Cryptosporidium: A Hierarchical Bayesian Analysis of Human Dose Response Data. Water Research. 35 (16), 3934–3940.
- ↑ Messner MJ, Chappell CL and Okhuysen PC (2001) Risk Assessment for Cryptosporidium: A Hierarchical Bayesian Analysis of Human Dose Response Data. Water Research. 35 (16), 3934–3940.
- ↑ Coster TS, Wolf MK, Hall ER, Cassels FJ, Taylor DN, Liu CT, Trespalacios FC, DeLorimier A, Angleberger DR and McQueen CE (2007) Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infection and immunity. 75 (1), 252–259.
- ↑ Coster TS, Wolf MK, Hall ER, Cassels FJ, Taylor DN, Liu CT, Trespalacios FC, DeLorimier A, Angleberger DR and McQueen CE (2007) Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infection and immunity. 75 (1), 252–259.
- ↑ Graham DY, Estes MK and Gentry LO (1983) Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers. Gastroenterology. 85 (5), 1017–1022.
- ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
- ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
- ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
- ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
- ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
- ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
- ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
- ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
- ↑ Tacket CO, Sztein MB, Losonsky G, Abe A, Finlay BB, McNamara BP, Fantry GT, James SP, Nataro JP, Levine MM and Donnenberg MS (2000) Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68 (6), 3689–3695.
- ↑ Tacket CO, Sztein MB, Losonsky G, Abe A, Finlay BB, McNamara BP, Fantry GT, James SP, Nataro JP, Levine MM and Donnenberg MS (2000) Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68 (6), 3689–3695.
- ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
- ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
- ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
- ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
- ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
- ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
- ↑ Clements ML, Levine MM, Black RE, Robins-Browne RM, Cisneros LA, Drusano GL, Lanata CF and Saah AJ (1981) Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrobial Agents and Chemotherapy. 20 (1), 104–108.
- ↑ Clements ML, Levine MM, Black RE, Robins-Browne RM, Cisneros LA, Drusano GL, Lanata CF and Saah AJ (1981) Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrobial Agents and Chemotherapy. 20 (1), 104–108.
- ↑ Clements ML, Levine MM, Black RE, Robins-Browne RM, Cisneros LA, Drusano GL, Lanata CF and Saah AJ (1981) Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrobial Agents and Chemotherapy. 20 (1), 104–108.
- ↑ Clements ML, Levine MM, Black RE, Robins-Browne RM, Cisneros LA, Drusano GL, Lanata CF and Saah AJ (1981) Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrobial Agents and Chemotherapy. 20 (1), 104–108.
- ↑ Levine MM, Caplan ES, Waterman D, Cash RA, Hornick RB and Snyder MJ (1977) Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infection and Immunity. 17 (1), 78–82.
- ↑ Levine MM, Caplan ES, Waterman D, Cash RA, Hornick RB and Snyder MJ (1977) Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infection and Immunity. 17 (1), 78–82.
- ↑ Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP and Hornick RB (1974) Response of Man to Infection with Vibrio cholerae. I. Clinical, Serologic, and Bacteriologic Responses to a Known Inoculum. The Journal of Infectious Diseases. 129 (1), 45–52.
- ↑ Levine MM, Black RE, Brinton CC Jr, Clements ML, Fusco P, Hughes TP, O’Donnell S, Robins-Browne R, Wood S and Young CR (1982) Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scandinavian journal of infectious diseases. Supplementum. 33, 83–95.
- ↑ Levine MM, Black RE, Brinton CC Jr, Clements ML, Fusco P, Hughes TP, O’Donnell S, Robins-Browne R, Wood S and Young CR (1982) Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scandinavian journal of infectious diseases. Supplementum. 33, 83–95.
- ↑ Levine MM, Rennels MB, Cisneros L, Hughes TP, Nalin DR and Young CR (1980) Lack of Person-to-Person Transmission of Enterotoxigenic Escherichia Coli Despite Close Contact. American Journal of Epidemiology. 111 (3), 347–355.
- ↑ Levine MM, Rennels MB, Cisneros L, Hughes TP, Nalin DR and Young CR (1980) Lack of Person-to-Person Transmission of Enterotoxigenic Escherichia Coli Despite Close Contact. American Journal of Epidemiology. 111 (3), 347–355.
- ↑ Levine MM, Rennels MB, Cisneros L, Hughes TP, Nalin DR and Young CR (1980) Lack of Person-to-Person Transmission of Enterotoxigenic Escherichia Coli Despite Close Contact. American Journal of Epidemiology. 111 (3), 347–355.
- ↑ Teunis PFM, Moe CL, Liu P, E. Miller S, Lindesmith L, Baric RS, Le Pendu J and Calderon RL (2008) Norwalk virus: How infectious is it? Journal of Medical Virology. 80 (8), 1468–1476.
- ↑ Teunis PFM, Moe CL, Liu P, E. Miller S, Lindesmith L, Baric RS, Le Pendu J and Calderon RL (2008) Norwalk virus: How infectious is it? Journal of Medical Virology. 80 (8), 1468–1476.
- ↑ Teunis PFM, Moe CL, Liu P, E. Miller S, Lindesmith L, Baric RS, Le Pendu J and Calderon RL (2008) Norwalk virus: How infectious is it? Journal of Medical Virology. 80 (8), 1468–1476.
- ↑ Teunis PFM, Moe CL, Liu P, E. Miller S, Lindesmith L, Baric RS, Le Pendu J and Calderon RL (2008) Norwalk virus: How infectious is it? Journal of Medical Virology. 80 (8), 1468–1476.
- ↑ Pai CH, Kelly JK and Meyers GL (1986) Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infection and Immunity. 51 (1), 16–23.
- ↑ Pai CH, Kelly JK and Meyers GL (1986) Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infection and Immunity. 51 (1), 16–23.
- ↑ Pai CH, Kelly JK and Meyers GL (1986) Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infection and Immunity. 51 (1), 16–23.
- ↑ Chappell CL, Okhuysen PC, Langer-Curry R, Widmer G, Akiyoshi DE, Tanriverdi S and Tzipori S (2006) Cryptosporidium Hominis: Experimental Challenge of Healthy Adults. The American Journal of Tropical Medicine and Hygiene. 75 (5), 851–857.
- ↑ Chappell CL, Okhuysen PC, Langer-Curry R, Widmer G, Akiyoshi DE, Tanriverdi S and Tzipori S (2006) Cryptosporidium Hominis: Experimental Challenge of Healthy Adults. The American Journal of Tropical Medicine and Hygiene. 75 (5), 851–857.
- ↑ Okhuysen PC, Rich SM, Chappell CL, Grimes KA, Widmer G, Feng X and Tzipori S (2002) Infectivity of a Cryptosporidium parvum Isolate of Cervine Origin for Healthy Adults and Interferon-γ Knockout Mice. Journal of Infectious Diseases. 185 (9), 1320–1325.
- ↑ Okhuysen PC, Rich SM, Chappell CL, Grimes KA, Widmer G, Feng X and Tzipori S (2002) Infectivity of a Cryptosporidium parvum Isolate of Cervine Origin for Healthy Adults and Interferon-γ Knockout Mice. Journal of Infectious Diseases. 185 (9), 1320–1325.
- ↑ Blaser MJ, Duncan DJ, Warren GH and Wang W-LL (1983) Experimental Campylobacter jejuni Infection of Adult Mice. Infection and Immunity. 39 (2), 908–916.
- ↑ Blaser MJ, Duncan DJ, Warren GH and Wang W-LL (1983) Experimental Campylobacter jejuni Infection of Adult Mice. Infection and Immunity. 39 (2), 908–916.
- ↑ Blaser MJ, Duncan DJ, Warren GH and Wang W-LL (1983) Experimental Campylobacter jejuni Infection of Adult Mice. Infection and Immunity. 39 (2), 908–916.
- ↑ Tribble DR, Baqar S, Carmolli MP, Porter C, Pierce KK, Sadigh K, Guerry P, Larsson CJ, Rockabrand D, Ventone CH, Poly F, Lyon CE, Dakdouk S, Fingar A, Gilliland T, Daunais P, Jones E, Rymarchyk S, Huston C, Darsley M and Kirkpatrick BD (2009) Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49 (10), 1512–1519.
- ↑ Tribble DR, Baqar S, Scott DA, Oplinger ML, Trespalacios F, Rollins D, Walker RI, Clements JD, Walz S, Gibbs P, Burg EF, Moran AP, Applebee L and Bourgeois AL (2010) Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in Humans. Infection and Immunity. 78 (4), 1750–1759.
- ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
- ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
- ↑ Cornick NA and Helgerson AF (2004) Transmission and Infectious Dose of Escherichia coli O157:H7 in Swine. Applied and Environmental Microbiology. 70 (9), 5331–5335.
- ↑ Bieber D, Ramer SW, Wu C-Y, Murray WJ, Tobe T, Fernandez R and Schoolnik GK (1998) Type IV Pili, Transient Bacterial Aggregates, and Virulence of Enteropathogenic Escherichia coli. Science. 280 (5372), 2114–2118.
- ↑ Levine MM, DuPont HL, Formal SB, Hornick RB, Takeuchi A, Gangarosa EJ, Snyder MJ and Libonati JP (1973) Pathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery. Journal of Infectious Diseases. 127 (3), 261–270.
- ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
- ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
- ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
- ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
- ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
- ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
- ↑ Black RE, Brown KH, Becker S, Alim ARMA and Huq I (1982) Longitudinal Studies of Infectious Diseases and Physical Growth of Children in Rural Bangladesh Ii. Incidence of Diarrhea and Association with Known Pathogens. American Journal of Epidemiology. 115 (3), 315–324.
- ↑ Bartrand TA, Weir MH and Haas CN (2008) Dose-Response Models for Inhalation of Bacillus anthracis Spores: Interspecies Comparisons. Risk Analysis. 28 (4), 1115–1124.
- ↑ DuPont HL, Levine MM, Hornick RB and Formal SB (1989) Inoculum Size in Shigellosis and Implications for Expected Mode of Transmission. Journal of Infectious Diseases. 159 (6), 1126–1128.
- ↑ DuPont HL, Levine MM, Hornick RB and Formal SB (1989) Inoculum Size in Shigellosis and Implications for Expected Mode of Transmission. Journal of Infectious Diseases. 159 (6), 1126–1128.
- ↑ DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB and Jakubowski W (1995) The infectivity of Cryptosporidium parvum in healthy volunteers. The New England journal of medicine. 332 (13), 855–859.
- ↑ Strachan NJC, Doyle MP, Kasuga F, Rotariu O and Ogden ID (2005) Dose response modelling of Escherichia coli O157 incorporating data from foodborne and environmental outbreaks. International Journal of Food Microbiology. 103 (1), 35–47.
- ↑ Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A and Dolin R (1988) Field trial of rhesus rotavirus vaccine in infants. The Pediatric infectious disease journal. 7 (9), 645–650.
- ↑ Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A and Dolin R (1988) Field trial of rhesus rotavirus vaccine in infants. The Pediatric infectious disease journal. 7 (9), 645–650.
- ↑ Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A and Dolin R (1988) Field trial of rhesus rotavirus vaccine in infants. The Pediatric infectious disease journal. 7 (9), 645–650.
- ↑ Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A and Dolin R (1988) Field trial of rhesus rotavirus vaccine in infants. The Pediatric infectious disease journal. 7 (9), 645–650.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
- ↑ Muller D, Edwards ML and Smith DW (1983) Changes in Iron and Transferrin Levels and Body Temperature in Experimental Airborne Legionellosis. The Journal of Infectious Diseases. 147 (2), 302–307.
- ↑ Fitzgeorge RB, Baskerville A, Broster M, Hambleton P and Dennis PJ (1983) Aerosol infection of animals with strains of Legionella pneumophila of different virulence: comparison with intraperitoneal and intranasal routes of infection. Epidemiology & Infection. 90 (01), 81–89.
- ↑ Breiman RF and Horwitz MA (1987) Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens. The Journal of Experimental Medicine. 165 (3), 799–811.
- ↑ Saslaw S and Carlisle HN (1966) Aerosol infection of monkeys with Rickettsia rickettsii. Bacteriological Reviews. 30 (3), 636–645.
- ↑ Sammons LS, Kenyon RH and Pedersen CE (1976) Effect of vaccination schedule on immune response of Macaca mulatta to cell culture-grown Rocky Mountain spotted fever vaccine. Journal of Clinical Microbiology. 4 (3), 253–257.
- ↑ Meynell GG and Meynell EW (1958) The growth of micro-organisms in vivo with particular reference to the relation between dose and latent period. Epidemiology & Infection. 56 (03), 323–346.
- ↑ Meynell GG and Meynell EW (1958) The growth of micro-organisms in vivo with particular reference to the relation between dose and latent period. Epidemiology & Infection. 56 (03), 323–346.
- ↑ Meynell GG and Meynell EW (1958) The growth of micro-organisms in vivo with particular reference to the relation between dose and latent period. Epidemiology & Infection. 56 (03), 323–346.
- ↑ Hornick RB, Music SI, Wenzel R, Cash R, Libonati JP, Snyder MJ and Woodward TE (1971) The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bulletin of the New York Academy of Medicine. 47 (10), 1181–1191.
- ↑ Diringer H, Roehmel J and Beekes M (1998) Effect of repeated oral infection of hamsters with scrapie. Journal of General Virology. 79 (3), 609–612.
- ↑ Jacquemot C, Cuche C, Dormont D and Lazarini F (2005) High Incidence of Scrapie Induced by Repeated Injections of Subinfectious Prion Doses. Journal of Virology. 79 (14), 8904–8908.
- ↑ Taylor DM, Woodgate SL and Atkinson MJ (1995) Inactivation of the bovine spongiform encephalopathy agent by rendering procedures. Veterinary Record. 137 (24), 605–610.
- ↑ John DT and Hoppe KL (1990) Susceptibility of Wild Mammals to Infection with Naegleria fowleri. The Journal of Parasitology. 76 (6), 865–868.
- ↑ John DT and Hoppe KL (1990) Susceptibility of Wild Mammals to Infection with Naegleria fowleri. The Journal of Parasitology. 76 (6), 865–868.
- ↑ Couch RB, Cate TR, Douglas RG, Gerone PJ and Knight V (1966) Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriological Reviews. 30 (3), 517–529.
- ↑ Schiff GM, Stefanović GM, Young EC, Sander DS, Pennekamp JK and Ward RL (1984) Studies of echovirus-12 in volunteers: determination of minimal infectious dose and the effect of previous infection on infectious dose. The Journal of infectious diseases. 150 (6), 858–866.
- ↑ Murphy BR, Clements ML, Madore HP, Steinberg J, O’Donnell S, Betts R, Demico D, Reichman RC, Dolin R and Maassab HF (1984) Dose Response of Cold-Adapted, Reassortant Influenza A/California/10/78 Virus (H1N1) in Adult Volunteers. Journal of Infectious Diseases. 149 (5), 816–816.
- ↑ Murphy BR, Clements ML, Tierney EL, Black RE, Stienberg J and Chanock RM (1985) Dose Response of Influenza A/Washington/897/80 (H3N2) Avian-Human Reassortant Virus in Adult Volunteers. The Journal of Infectious Diseases. 152 (1), 225–229.
- ↑ Fan S, Deng G, Song J, Tian G, Suo Y, Jiang Y, Guan Y, Bu Z, Kawaoka Y and Chen H (2009) Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology. 384 (1), 28–32.
- ↑ DeDiego ML, Pewe L, Alvarez E, Rejas MT, Perlman S and Enjuanes L (2008) Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice. Virology. 376 (2), 379–389.
- ↑ Albuquerque ND, Baig E, Ma X, Zhang J, He W, Rowe A, Habal M, Liu M, Shalev I, Downey GP, Gorczynski R, Butany J, Leibowitz J, Weiss SR, McGilvray ID, Phillips MJ, Fish EN and Levy GA (2006) Murine Hepatitis Virus Strain 1 Produces a Clinically Relevant Model of Severe Acute Respiratory Syndrome in A/J Mice. Journal of Virology. 80 (21), 10382–10394.
- ↑ O’Brien R, Mackintosh CG, Bakker D, Kopecna M, Pavlik I and Griffin JFT (2006) Immunological and Molecular Characterization of Susceptibility in Relationship to Bacterial Strain Differences in Mycobacterium avium subsp. paratuberculosis Infection in the Red Deer (Cervus elaphus). Infection and Immunity. 74 (6), 3530–3537.
- ↑ NISBET DI, GILMOUR NJ and BROTHERSTON JG (1962) Quantitative studies of Mycobacterium johnei in tissues of sheep. III. Intestinal histopathology. Journal of comparative pathology. 72, 80–91.
- ↑ Badenoch PR, Johnson AM, Christy PE and Coster DJ (1990) Pathogenicity of Acanthamoeba and a Corynebacterium in the Rat Cornea. Archives of Ophthalmology. 108 (1), 107–112.
- ↑ Badenoch PR, Johnson AM, Christy PE and Coster DJ (1990) Pathogenicity of Acanthamoeba and a Corynebacterium in the Rat Cornea. Archives of Ophthalmology. 108 (1), 107–112.
- ↑ Cerva L (1967-2) Intracerebral Inoculation of Experimental Animals in Pathogenetical Studies of Hartmannella Castellanii . Folia Parastologica. 14,171-176
- ↑ Cerva L (1967-2) Intracerebral Inoculation of Experimental Animals in Pathogenetical Studies of Hartmannella Castellanii . Folia Parastologica. 14,171-176
- ↑ Cerva L (1967-2) Intracerebral Inoculation of Experimental Animals in Pathogenetical Studies of Hartmannella Castellanii . Folia Parastologica. 14,171-176
- ↑ Cerva L (1967-2) Intracerebral Inoculation of Experimental Animals in Pathogenetical Studies of Hartmannella Castellanii . Folia Parastologica. 14,171-176
- ↑ Culbertson CG, Ensminger PW and Overton WM (1966) Hartmannella (acanthamoeba). Experimental chronic, granulomatous brain infections produced by new isolates of low virulence. American journal of clinical pathology. 46 (3), 305–314.
- ↑ Culbertson CG, Ensminger PW and Overton WM (1966) Hartmannella (acanthamoeba). Experimental chronic, granulomatous brain infections produced by new isolates of low virulence. American journal of clinical pathology. 46 (3), 305–314.
- ↑ Culbertson CG, Ensminger PW and Overton WM (1966) Hartmannella (acanthamoeba). Experimental chronic, granulomatous brain infections produced by new isolates of low virulence. American journal of clinical pathology. 46 (3), 305–314.
- ↑ Culbertson CG, Ensminger PW and Overton WM (1966) Hartmannella (acanthamoeba). Experimental chronic, granulomatous brain infections produced by new isolates of low virulence. American journal of clinical pathology. 46 (3), 305–314.
- ↑ Day WC and Berendt RF (1972) Experimental Tularemia in Macaca mulatta: Relationship of Aerosol Particle Size to the Infectivity of Airborne Pasteurella tularensis. Infection and Immunity. 5 (1), 77–82.
- ↑ Quan SF, McManus AG and H. von Fintel (1956) Infectivity of Tularemia Applied to Intact Skin and Ingested in Drinking Water. Science. 123 (3204), 942–943.
- ↑ John DT and Hoppe KL (1990) Susceptibility of Wild Mammals to Infection with Naegleria fowleri. The Journal of Parasitology. 76 (6), 865–868.
- ↑ John DT and Hoppe KL (1990) Susceptibility of Wild Mammals to Infection with Naegleria fowleri. The Journal of Parasitology. 76 (6), 865–868.
- ↑ Rose JB and Haas CN (1999) A risk assessment framework for the evaluation of skin infections and the potential impact of antibacterial soap washing. American Journal of Infection Control. 27 (6), S26–S33.
- ↑ Lawin-Brüssel CA, Refojo MF, Leong FL, Hanninen L and Kenyon KR (1993) Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. Cornea. 12 (1), 10–18.
- ↑ Lawin-Brüssel CA, Refojo MF, Leong FL, Hanninen L and Kenyon KR (1993) Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. Cornea. 12 (1), 10–18.
- ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
- ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
- ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
- ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
- ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
- ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
- ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
- ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
- ↑ Smith MA, Takeuchi K, Anderson G, Ware GO, McClure HM, Raybourne RB, Mytle N and Doyle MP (2008) Dose-Response Model for Listeria monocytogenes-Induced Stillbirths in Nonhuman Primates. Infection and Immunity. 76 (2), 726–731.
- ↑ Williams D, Irvin EA, Chmielewski RA and Frank JF (May) Dose-Response of Listeria monocytogenes after Oral Exposure in Pregnant Guinea Pigs. Journal of Food Protection. 70 (5), 1122–1128.
- ↑ Golnazarian CA, Donnelly CW, Pintauro SJ and Howard DB Comparison of infectious dose of Listeria monocytogenes F5817 as determined for normal versus compromised C57B1/6J mice. Journal of food protection. 52 (10), 696–701.
- ↑ Golnazarian CA, Donnelly CW, Pintauro SJ and Howard DB Comparison of infectious dose of Listeria monocytogenes F5817 as determined for normal versus compromised C57B1/6J mice. Journal of food protection. 52 (10), 696–701.
- ↑ Czuprynski CJ, Faith NG and Steinberg H (2003) A/J Mice Are Susceptible and C57BL/6 Mice Are Resistant to Listeria monocytogenes Infection by Intragastric Inoculation. Infection and Immunity. 71 (2), 682–689.
- ↑ Czuprynski CJ, Faith NG and Steinberg H (2003) A/J Mice Are Susceptible and C57BL/6 Mice Are Resistant to Listeria monocytogenes Infection by Intragastric Inoculation. Infection and Immunity. 71 (2), 682–689.
- ↑ Golnazarian CA, Donnelly CW, Pintauro SJ and Howard DB Comparison of infectious dose of Listeria monocytogenes F5817 as determined for normal versus compromised C57B1/6J mice. Journal of food protection. 52 (10), 696–701.
- ↑ Audurier A, Pardon P, Marly J and Lantier F (1980) Experimental infection of mice with Listeria monocytogenes and L. innocua. Annales de microbiologie. 131B (1), 47–57.
- ↑ Lawin-Brüssel CA, Refojo MF, Leong FL, Hanninen L and Kenyon KR (1993) Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. Cornea. 12 (1), 10–18.
- ↑ Lawin-Brüssel CA, Refojo MF, Leong FL, Hanninen L and Kenyon KR (1993) Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. Cornea. 12 (1), 10–18.